Literature DB >> 18396621

[Removal and plastic reconstructive surgery of orbital neurofibroma].

Xian-Qun Fan1, Ming Lin, Jin Li, Hui-Fang Zhou, Yao Fu.   

Abstract

OBJECTIVE: To investigate the safety and efficacy of surgical management of orbital neurofibroma (NF).
METHODS: Twenty-six patients with orbitotemporal NF underwent tumor resection. And then 12 of the 26 patients that were of Jackson group I, underwent blepharoplasty surgery, including lid plastic and reconstructive surgery, lateral canthal reattachment and ptosis surgery. Ten patients of group II underwent blepharoplasty combined with orbital reconstruction. And 4 patients of group III underwent blepharoplasty surgery, orbital reconstruction, and hydroxyapatite orbital implanting. The functionally useless eyes of 2 patients were retained for cosmetic appearance.
RESULTS: There was no recrudescence after neurofibroma resection. 10 patients had their vision acuity improved. All patients obtained satisfying results after eyelid and orbital plastic surgery. 2 patients relapsed into ptosis that was cured with further frontalis suspension procedure with autogenous fascia lata.
CONCLUSION: Neurofibroma removal surgery is a safe and effective treatment method for NF patients. The periorbital appearance and visual acuity of patients with orbitotemporal NF can be significantly improved through oculoplastic surgery.

Entities:  

Mesh:

Year:  2007        PMID: 18396621

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  2 in total

1.  Recurrent orbital space-occupying lesions: a clinicopathologic study of 253 cases.

Authors:  Weiqiang Tang; Yan Hei; Lihua Xiao
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

2.  Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome.

Authors:  I A Chaudhry; J Morales; F A Shamsi; W Al-Rashed; E Elzaridi; Y O Arat; C Jacquemin; D T Oystreck; T M Bosley
Journal:  Eye (Lond)       Date:  2011-12-23       Impact factor: 3.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.